Market Value2,505,998,000
Total Holdings67
File Date2020-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Call
CCXI / ChemoCentryx Inc
CCXI / ChemoCentryx Inc Call
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
PHAS / PhaseBio Pharmaceuticals Inc
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
US62857M1053 / MyoKardia, Inc.
ITRM / Iterum Therapeutics plc
FIXX / Homology Medicines, Inc.
IMVTU / Immunovant, Inc. Units
US9266131005 / Viela Bio, Inc.
SRRK / Scholar Rock Holding Corporation
KURA / Kura Oncology, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
DTIL / Precision BioSciences, Inc.
BOLD / Boundless Bio, Inc.
IGMS / IGM Biosciences, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
TWST / Twist Bioscience Corporation
859319303 / Sterling Financial Corp
MYOV / Myovant Sciences Ltd
GTHX / G1 Therapeutics, Inc.
NKTR / Nektar Therapeutics
EIGR / Eiger BioPharmaceuticals, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
QTNT / Quotient Ltd
ABEO / Abeona Therapeutics Inc.
RARX / Ra Pharmaceuticals, Inc.
US74257L1089 / Principia Biopharma Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
NERV / Minerva Neurosciences, Inc.
SPY / SPDR S&P 500 ETF Put
RETA / Reata Pharmaceuticals Inc - Class A Call
SRPT / Sarepta Therapeutics, Inc.
NXTC / NextCure, Inc.
INSP / Inspire Medical Systems, Inc.
GOSS / Gossamer Bio, Inc.
ARNA / Arena Pharmaceuticals Inc
RETA / Reata Pharmaceuticals Inc - Class A
TCDA / Tricida Inc
DCPH / Deciphera Pharmaceuticals, Inc.
OTLK / Outlook Therapeutics, Inc.
IFRX / InflaRx N.V.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
MRUS / Merus N.V.
QURE / uniQure N.V.
XLRN / Acceleron Pharma Inc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ZYME / Zymeworks Inc.
SRNE / Sorrento Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
RUBY / Rubius Therapeutics, Inc.
KZR / Kezar Life Sciences, Inc.
AVRO / AVROBIO, Inc.
SAGE / Sage Therapeutics, Inc.
GNFTF / Genfit S.A.
TBPH / Theravance Biopharma, Inc.
ATRA / Atara Biotherapeutics, Inc.
CRSP / CRISPR Therapeutics AG
ADVM / Adverum Biotechnologies, Inc. Call
NBIX / Neurocrine Biosciences, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
HARP / Harpoon Therapeutics, Inc.
ALLK / Allakos Inc.
ANAB / AnaptysBio, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
OMER / Omeros Corporation
AKRO / Akero Therapeutics, Inc.
XFOR / X4 Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
MRTX / Mirati Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc. Call
MRTX / Mirati Therapeutics, Inc. Put
BPMC / Blueprint Medicines Corporation
BHVN / Biohaven Ltd.
CABA / Cabaletta Bio, Inc.
AXNX / Axonics, Inc.
BCEL / Atreca, Inc.
STOK / Stoke Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
TPTX / Turning Point Therapeutics Inc
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
RCKT / Rocket Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
BBIO / BridgeBio Pharma, Inc.
BHVN / Biohaven Ltd. Call